Safety and Efficacy of Two Types of Botulinum Toxin Type A For the Treatment of Glabellar Lines

This study will evaluate the safety and efficacy of two different types of botulinum toxin type A for the treatment of glabellar frown lines.

Inclusion Criteria:

• Moderate to severe glabellar frown lines

Exclusion Criteria:

• Diagnosis of myasthenia gravis or Eaton Lambert syndrome
• Aesthetic treatment with botulinum toxin within 6 months or planned treatment with botulinum toxin for any reason during the study
• Prior filler treatments, surgeries, insertion procedures in/to the glabellar region
• Facial cosmetic procedures in the glabellar area within 6 months
• Bleeding disorders or use of anticoagulants within 10 days
• History of facial nerve palsy